Company news

Codexis, Inc. news in 2024

Codexis, Inc.'s news releases, calls and decks from 2024, newest first.

View company

Codexis to Participate in Piper Sandler 36th Annual Healthcare Conference

November 18, 2024

Codexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi Therapeutics

November 13, 2024

Codexis Announces Appointment of Raymond De Vré, PhD, to Board of Directors

November 11, 2024

Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for RNAi Therapeutics

November 10, 2024

Codexis to Participate in Upcoming Healthcare Conferences

November 3, 2024

Codexis Reports Third Quarter 2024 Financial Results

October 30, 2024

Codexis Announces Three siRNA Manufacturing Data Presentations at TIDES Europe Annual Meeting

October 23, 2024

Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors

October 21, 2024

Codexis to Report Third Quarter 2024 Financial Results on October 31

October 9, 2024

Codexis Increases Cash Reserves and Enhances Management Team to Fuel Growth of Company

October 1, 2024

Codexis Licenses Genomics Life Science Enzyme Portfolio to Alphazyme LLC, part of Maravai LifeSciences

September 30, 2024

Codexis to Participate in Enzymatic Synthesis Presentations at RNA Leaders Annual Meeting

August 19, 2024

Codexis Publishes FY2023 Sustainability Disclosures

August 14, 2024

Codexis Reports Second Quarter 2024 Financial Results

August 7, 2024

Codexis to Report Second Quarter 2024 Financial Results on August 8

July 17, 2024

Codexis Finalizes Purchase Agreement with Crosswalk Therapeutics for Gene Therapy Assets

June 30, 2024

Codexis to Participate in TD Cowen 2nd Annual Sustainability Week

May 19, 2024

Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual Meeting

May 13, 2024

Codexis Reports First Quarter 2024 Financial Results

May 1, 2024

Codexis to Report First Quarter 2024 Financial Results on May 2

April 17, 2024

Codexis Appoints Carole Cobb, MBA, to Strategic Advisory Board

April 10, 2024

Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial Results

February 27, 2024

Codexis to Participate in TD Cowen 44th Annual Health Care Conference

February 25, 2024

Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with Roche

February 25, 2024

Codexis Announces Appointment of Masad Damha, PhD, and Jim Lalonde, PhD, to Strategic Advisory Board

February 19, 2024

Codexis to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 28

February 13, 2024

Codexis Secures $40 Million in Strategic Financing Deal with Innovatus Capital Partners to Further Strengthen Cash Position Ahead of Key Milestones

February 12, 2024

seqWell and Codexis to Unveil Engineered Transposase Enzyme for Genomics Applications at AGBT General Meeting

January 31, 2024

Calls in 2024

Decks in 2024